Form 4: Century Therapeutics Executive Sells Shares for Tax

Chief Technology and Manufacturing Officer Gregory Russotti sold 2,584 shares of Century Therapeutics to cover tax obligations.

Summary

• Gregory Russotti, Chief Technology and Manufacturing Officer of Century Therapeutics, Inc. (IPSC), sold 2,584 shares of common stock.
• The transaction occurred on June 12, 2026, at a price of $2.232 per share.
• The sale was executed automatically to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, the reporting person holds 512,319 shares directly and 92,773 shares indirectly through a family trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was mandatory for tax purposes and does not reflect a change in the executive's outlook on the company.

Positives

• The sale was non-discretionary and strictly for tax compliance purposes, indicating no change in long-term investment sentiment.

Negatives

• Reduction in direct equity ownership by the executive.

Risks

• None identified; this is a routine administrative transaction.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that automatic sell-to-cover transactions are standard practice for executives in the biotechnology sector to manage tax liabilities upon the vesting of equity-based compensation.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for executive compensation and tax management.

Stakeholder Impact

• Minimal impact on shareholders as the sale was automatic and small relative to total holdings.

Next Steps

• None

Key Dates

Keywords

Century Therapeutics, IPSC, Insider Trading, Form 4, Biotech, Tax Withholding